Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 1999
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targetingR Haubner, H J Wester, U Reuning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardiumI Matsunari, F Haas, N T Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokineticsR Haubner, H J Wester, F Burkhart, et al.
The International Journal of Biological Markers|July 1, 1988
Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125R P Baum, M Lorenz, C Hottenrott, et al.
Leukemia & Lymphoma|August 1, 1996
Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytomaM Hallek, L Wanders, M Ostwald, et al.
Radiation Protection Dosimetry|December 22, 2006
The sensitivity of the alkaline comet assay in detecting DNA lesions induced by X rays, gamma rays and alpha particlesU Rössler, S Hornhardt, C Seidl, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 8, 1999
New drugs for BNCT: an experimental approachL Weissfloch, M Bremer, P Lemmen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2004
Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximabG-J Beyer, M Miederer, S Vranjes-Durić, et al.
Cancer Research|March 31, 2001
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomographyR Haubner, H J Wester, W A Weber, et al.
Gene Therapy|October 6, 2012
Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirusG K Grünwald, K Klutz, M J Willhauck, et al.
Pageof 7